BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27631008)

  • 21. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
    Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression profiles of lipid metabolism-related genes in liver of apoE(-/-)/LDLR(-/-) mice].
    Du HQ; Yin M; Ye HY; Shang YJ; Dai XD; Jing W; Zhang L; Xiao N; Li JF; Pan J
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):751-5. PubMed ID: 18307880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simvastatin suppresses apoptosis in vulnerable atherosclerotic plaques through regulating the expression of p(53), Bcl-2 and Bcl-xL.
    Qin W; Lu Y; Zhan C; Shen T; Dou L; Man Y; Wang S; Xiao C; Bian Y; Li J
    Cardiovasc Drugs Ther; 2012 Feb; 26(1):23-30. PubMed ID: 22038096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Smad decoy ODN on shear stress-induced atherosclerotic ApoE-/-mouse.
    An HJ; Lee WR; Kim KH; Kim JY; Kim WH; Park KK; Youn SW
    Int J Clin Exp Pathol; 2015; 8(4):3971-8. PubMed ID: 26097583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet.
    Papadopoulos P; Bousette N; Al-Ramli W; You Z; Behm DJ; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Atherosclerosis; 2009 Jun; 204(2):395-404. PubMed ID: 19111831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanostructured lipid carriers accumulate in atherosclerotic plaques of ApoE
    Vigne J; Cabella C; Dézsi L; Rustique E; Couffin AC; Aid R; Anizan N; Chauvierre C; Letourneur D; Le Guludec D; Rouzet F; Hyafil F; Mészáros T; Fülöp T; Szebeni J; Cordaro A; Oliva P; Mourier V; Texier I
    Nanomedicine; 2020 Apr; 25():102157. PubMed ID: 31982616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of atherogenic lipidome by cigarette smoke in apolipoprotein E-deficient mice.
    Boué S; Tarasov K; Jänis M; Lebrun S; Hurme R; Schlage W; Lietz M; Vuillaume G; Ekroos K; Steffen Y; Peitsch MC; Laaksonen R; Hoeng J
    Atherosclerosis; 2012 Dec; 225(2):328-34. PubMed ID: 23102783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of JAZF1 protected ApoE-deficient mice from atherosclerosis by inhibiting hepatic cholesterol synthesis via CREB-dependent mechanisms.
    Li X; Yang M; Wang H; Jia Y; Yan P; Boden G; Yang G; Li L
    Int J Cardiol; 2014 Nov; 177(1):100-10. PubMed ID: 25499349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
    Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
    Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered cellular redox status, sirtuin abundance and clock gene expression in a mouse model of developmentally primed NASH.
    Bruce KD; Szczepankiewicz D; Sihota KK; Ravindraanandan M; Thomas H; Lillycrop KA; Burdge GC; Hanson MA; Byrne CD; Cagampang FR
    Biochim Biophys Acta; 2016 Jul; 1861(7):584-93. PubMed ID: 27040510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased levels of lipid peroxidation-induced DNA damage in the onset of atherogenesis in apolipoprotein E deficient mice.
    Godschalk RW; Albrecht C; Curfs DM; Schins RP; Bartsch H; van Schooten FJ; Nair J
    Mutat Res; 2007 Aug; 621(1-2):87-94. PubMed ID: 17418875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of simvastatin on plasma lipoproteins and hearing loss in apolipoprotein E gene-deficient mice.
    Cai Q; Du X; Zhou B; Cai C; Kermany MH; Zhang C; Yoo T
    ORL J Otorhinolaryngol Relat Spec; 2009; 71(5):244-50. PubMed ID: 19738398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rhythm changes of clock genes, apoptosis-related genes and atherosclerosis-related genes in apolipoprotein E knockout mice.
    Xu C; Lu C; Hua L; Jin H; Yin L; Chen S; Qian R
    Can J Cardiol; 2009 Aug; 25(8):473-9. PubMed ID: 19668782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuated atherogenesis in apolipoprotein E-deficient mice lacking amyloid precursor protein.
    Van De Parre TJ; Guns PJ; Fransen P; Martinet W; Bult H; Herman AG; De Meyer GR
    Atherosclerosis; 2011 May; 216(1):54-8. PubMed ID: 21316678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
    Harrington SC; Simari RD; Conover CA
    Circ Res; 2007 Jun; 100(12):1696-702. PubMed ID: 17510462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise attenuates matrix metalloproteinase activity in preexisting atherosclerotic plaque.
    Shon SM; Park JH; Nahrendorf M; Schellingerhout D; Kim JY; Kang BT; Jeong SW; Kim EJ; Ryu JH; Kim K; Kwon IC; Lee DK; Lee MM; Kim DE
    Atherosclerosis; 2011 May; 216(1):67-73. PubMed ID: 21334624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
    Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X
    Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
    Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valsartan Promoting Atherosclerotic Plaque Stabilization by Upregulating Renalase: A Potential-Related Gene of Atherosclerosis.
    Zhou M; Ma C; Liu W; Liu H; Wang N; Kang Q; Li P
    J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):509-19. PubMed ID: 25818930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic treatment with neuropeptide Y receptor Y1-antagonist enhances atherosclerosis and stimulates IL-12 expression in ApoE deficient mice.
    Jääskeläinen AE; Seppälä S; Kakko T; Jaakkola U; Kallio J
    Neuropeptides; 2013 Apr; 47(2):67-73. PubMed ID: 23261359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.